세계의 종양학 영양 시장 보고서(2025년)

Oncology nutrition involves the implementation of a healthy and balanced diet specifically tailored for cancer patients. Consuming the right types of food before, during, and after treatment is crucial for helping patients feel better and maintain strength. The goal of oncology nutrition is to enhance clinical outcomes in specific cancer types.

The primary categories of cancer addressed in oncology nutrition include blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others. Stomach and gastrointestinal cancers encompass malignancies occurring in any part of the stomach. Various nutritional approaches, such as enteral nutrition and parenteral nutrition, are employed across different settings, including hospitals, homecare, specialty clinics, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The oncology nutrition market research report is one of a series of new reports from The Business Research Company that provides oncology nutrition market statistics, including oncology nutrition industry global market size, regional shares, competitors with an oncology nutrition market share, detailed oncology nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. This oncology nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The oncology nutrition market size has grown strongly in recent years. It will grow from $1.9 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to aging population, improved healthcare infrastructure, research and development investments, patient-centric care, rise in healthcare spending.

The oncology nutrition market size is expected to see strong growth in the next few years. It will grow to $3 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing cancer incidence, rise in demand for nutritional food, increase in clinical trials globally, rising disposable income. Major trends in the forecast period include personalized nutrition, immuno-nutrition, genomic nutrition, integrative medicine, value-based care.

The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to increase expenses for immunonutrition formulas (Netherlands) and tube-feeding modules (Switzerland), thereby compromising malnutrition management in cancer patients and raising supportive care budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is a significant factor contributing to the anticipated growth of the oncology nutrition market. Cancer incidence, which refers to the number of new cancer cases within a specific population over a defined period, has been on the rise. Individuals undergoing cancer treatment require nutrition that meets their specific dietary needs, driving the demand for oncology nutrition products. For example, the American Cancer Society reported in January 2023 that the number of cancer cases had increased to 1,958,310 in 2023, marking a growth of 3.16% from 1,898,160 in 2021. Consequently, the escalating incidence of cancer is expected to be a driving force for the expansion of the oncology nutrition market.

The growth of the oncology nutrition market is also anticipated to be fueled by increasing investments in cancer research. Investment in cancer research involves allocating financial resources to support scientific endeavors aimed at understanding, preventing, diagnosing, and treating cancer. Heightened research funding facilitates a deeper comprehension of the intricate relationship between nutrition and cancer, leading to the development of specialized oncology nutrition products tailored to the unique dietary requirements of cancer patients. For instance, in March 2022, the Department of Health and Aged Care, a government agency based in Australia, allocated $893.5 million to enhance cancer services and outcomes. This increased investment in cancer research is expected to drive the growth of the oncology nutrition market.

Major companies in the oncology nutrition market are dedicated to developing innovative solutions, such as nutrition specifically tailored for cancer patients, to enhance treatment outcomes, support immune function, manage side effects related to treatment, and improve overall quality of life during and after cancer therapy. Nutrition for cancer patients encompasses specialized dietary plans and nutritional interventions aimed at addressing the unique needs of individuals undergoing cancer treatment. For example, in June 2024, AEACAP, a patient support association based in Spain, introduced a new nutrition series aimed at assisting cancer patients and their caregivers. This initiative includes a collection of videos released every two weeks, presented by a qualified nutritionist. The series seeks to offer vital information on diet and nutrition throughout and after cancer treatment, emphasizing the essential role that proper nutrition plays in improving treatment outcomes and enhancing the quality of life for those affected by cancer.

Major companies in the oncology nutrition market are focusing on the development of personalized nutrition products to gain a competitive edge. Tality, a medical food based on personalized nutrition designed to inhibit the growth of cancer cells within a short timeframe, is one such example. Filtricine Inc., a US-based biotechnology company, introduced Tality in September 2023, utilizing personalized nutrition to target nutrients essential for cancer cells while sparing normal cells. The Tality meal plan, known as the TND diet, can be used alongside standard patient care or as a standalone treatment, with potential benefits observable in as little as four weeks, according to early results.

In January 2024, Danone S.A., a food company based in France, formed a partnership with National Resilience, Inc. This collaboration aims to improve nutritional care for cancer patients by incorporating a specialized nutrition support module into Resilience's digital oncology platform, focusing on addressing cancer-related malnutrition and enhancing patient outcomes and quality of life during treatment. National Resilience, Inc., a manufacturing and technology company located in the U.S., is committed to expanding access to complex medicines.

Major companies operating in the oncology nutrition market include B. Braun Melsungen AG, Danone India, Abbott Laboratories, Nestle S.A., Hormel Foods Corporation, Meiji Holdings Co. Ltd., Pfizer Inc., Baxter International Inc., Mead Johnson Nutrition Company LLC, Fresenius Kabi AG, Mead Johnson & Company LLC, Global Health Products Inc., Nutricia, Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Abbott Nutrition, Fresenius Kabi USA LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Pinnacle Foods Inc., Primus Pharmaceuticals Inc., Solace Nutrition, The Simply Good Foods Company, Unimed Pharma LLC, Vitaflo USA LLC

North America was the largest region in the oncology nutrition market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the oncology nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The oncology nutrition market includes revenues earned by entities by bladder cancer, breast cancer, colorectal cancer, kidney cancer, and lung cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Nutrition Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncology nutrition market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology nutrition ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology nutrition market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cancer Type: Blood Cancer; Breast Cancer; Stomach and Gastrointestinal Cancers; Liver Cancer; Pancreatic Cancer; Other Cancer Types
• 2) By Nutrition: Enteral Nutrition; Parenteral Nutrition
• 3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Blood Cancer: Leukemia; Lymphoma; Multiple Myeloma
• 2) By Breast Cancer: Early-Stage Breast Cancer; Advanced Breast Cancer
• 3) By Stomach and Gastrointestinal Cancers: Gastric Cancer; Colorectal Cancer; Esophageal Cancer
• 4) By Liver Cancer: Hepatocellular Carcinoma; Cholangiocarcinoma
• 5) By Pancreatic Cancer: Exocrine Pancreatic Cancer; Endocrine Pancreatic Tumors
• 6) By Other Cancer Types: Lung Cancer; Prostate Cancer; Ovarian Cancer; Head And Neck Cancers
• Companies Mentioned: B. Braun Melsungen AG; Danone India; Abbott Laboratories; Nestle S.A.; Hormel Foods Corporation; Meiji Holdings Co. Ltd.; Pfizer Inc.; Baxter International Inc.; Mead Johnson Nutrition Company LLC; Fresenius Kabi AG; Mead Johnson & Company LLC; Global Health Products Inc.; Nutricia; Cambrooke Therapeutics Inc.; Kate Farms Inc.; Real Food Blends LLC; Abbott Nutrition; Fresenius Kabi USA LLC; Medtrition Inc.; Nutra Balance Products; Nutritional Medicinals LLC; Pinnacle Foods Inc.; Primus Pharmaceuticals Inc.; Solace Nutrition; The Simply Good Foods Company; Unimed Pharma LLC; Vitaflo USA LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oncology Nutrition Market Characteristics

3. Oncology Nutrition Market Trends And Strategies

4. Oncology Nutrition Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Oncology Nutrition Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oncology Nutrition PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oncology Nutrition Market Growth Rate Analysis
• 5.4. Global Oncology Nutrition Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oncology Nutrition Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oncology Nutrition Total Addressable Market (TAM)

6. Oncology Nutrition Market Segmentation

• 6.1. Global Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Cancer
• Breast Cancer
• Stomach and Gastrointestinal Cancers
• Liver Cancer
• Pancreatic Cancer
• Other Cancer Types
• 6.2. Global Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enteral Nutrition
• Parenteral Nutrition
• 6.3. Global Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.4. Global Oncology Nutrition Market, Sub-Segmentation Of Blood Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukemia
• Lymphoma
• Multiple Myeloma
• 6.5. Global Oncology Nutrition Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early-Stage Breast Cancer
• Advanced Breast Cancer
• 6.6. Global Oncology Nutrition Market, Sub-Segmentation Of Stomach and Gastrointestinal Cancers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastric Cancer
• Colorectal Cancer
• Esophageal Cancer
• 6.7. Global Oncology Nutrition Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatocellular Carcinoma
• Cholangiocarcinoma
• 6.8. Global Oncology Nutrition Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exocrine Pancreatic Cancer
• Endocrine Pancreatic Tumors
• 6.9. Global Oncology Nutrition Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Prostate Cancer
• Ovarian Cancer
• Head And Neck Cancers

7. Oncology Nutrition Market Regional And Country Analysis

• 7.1. Global Oncology Nutrition Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oncology Nutrition Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncology Nutrition Market

• 8.1. Asia-Pacific Oncology Nutrition Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncology Nutrition Market

• 9.1. China Oncology Nutrition Market Overview
• 9.2. China Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncology Nutrition Market

• 10.1. India Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncology Nutrition Market

• 11.1. Japan Oncology Nutrition Market Overview
• 11.2. Japan Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncology Nutrition Market

• 12.1. Australia Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncology Nutrition Market

• 13.1. Indonesia Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncology Nutrition Market

• 14.1. South Korea Oncology Nutrition Market Overview
• 14.2. South Korea Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncology Nutrition Market

• 15.1. Western Europe Oncology Nutrition Market Overview
• 15.2. Western Europe Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncology Nutrition Market

• 16.1. UK Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncology Nutrition Market

• 17.1. Germany Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncology Nutrition Market

• 18.1. France Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncology Nutrition Market

• 19.1. Italy Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncology Nutrition Market

• 20.1. Spain Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncology Nutrition Market

• 21.1. Eastern Europe Oncology Nutrition Market Overview
• 21.2. Eastern Europe Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncology Nutrition Market

• 22.1. Russia Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncology Nutrition Market

• 23.1. North America Oncology Nutrition Market Overview
• 23.2. North America Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncology Nutrition Market

• 24.1. USA Oncology Nutrition Market Overview
• 24.2. USA Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncology Nutrition Market

• 25.1. Canada Oncology Nutrition Market Overview
• 25.2. Canada Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncology Nutrition Market

• 26.1. South America Oncology Nutrition Market Overview
• 26.2. South America Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncology Nutrition Market

• 27.1. Brazil Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncology Nutrition Market

• 28.1. Middle East Oncology Nutrition Market Overview
• 28.2. Middle East Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncology Nutrition Market

• 29.1. Africa Oncology Nutrition Market Overview
• 29.2. Africa Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncology Nutrition Market Competitive Landscape And Company Profiles

• 30.1. Oncology Nutrition Market Competitive Landscape
• 30.2. Oncology Nutrition Market Company Profiles
  • 30.2.1. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danone India Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hormel Foods Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Oncology Nutrition Market Other Major And Innovative Companies

• 31.1. Meiji Holdings Co. Ltd.
• 31.2. Pfizer Inc.
• 31.3. Baxter International Inc.
• 31.4. Mead Johnson Nutrition Company LLC
• 31.5. Fresenius Kabi AG
• 31.6. Mead Johnson & Company LLC
• 31.7. Global Health Products Inc.
• 31.8. Nutricia
• 31.9. Cambrooke Therapeutics Inc.
• 31.10. Kate Farms Inc.
• 31.11. Real Food Blends LLC
• 31.12. Abbott Nutrition
• 31.13. Fresenius Kabi USA LLC
• 31.14. Medtrition Inc.
• 31.15. Nutra Balance Products

32. Global Oncology Nutrition Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncology Nutrition Market

34. Recent Developments In The Oncology Nutrition Market

35. Oncology Nutrition Market High Potential Countries, Segments and Strategies

• 35.1 Oncology Nutrition Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oncology Nutrition Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oncology Nutrition Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer